Teva pharma

In FY16, Intas’s revenues rose by 27.4% to `6,569 crore and its operating profit by 48.6% to `1,477 crore. There was a 58.4% increase in its net profit to `882 crore. This acquisition will add about `2,100 crore to revenues.

Intas: Wish you were listed

2 min read . 07 Oct 2016